| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |